BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28367947)

  • 21. [Case of amyloidosis with amyloid deposition detected only in skeletal muscles].
    Ohtsuka Y; Yasui N; Sekiguchi K; Kowa H; Nishino I; Kanda F; Toda T
    Rinsho Shinkeigaku; 2012; 52(10):739-43. PubMed ID: 23064623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-signal Recognition Particle Antibody-positive Necrotizing Myopathy with Secondary Cardiomyopathy: The First Myocardial Biopsy- and Multimodal Imaging-proven Case.
    Takeguchi-Kikuchi S; Hayasaka T; Katayama T; Kano K; Takahashi K; Saito T; Sawada J; Minoshima A; Sakamoto N; Akasaka K; Miyokawa N; Nishino I; Ishibashi-Ueda H; Hasebe N
    Intern Med; 2019 Nov; 58(21):3189-3194. PubMed ID: 31292376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
    Suzuki S; Hayashi YK; Kuwana M; Tsuburaya R; Suzuki N; Nishino I
    Arch Neurol; 2012 Jun; 69(6):728-32. PubMed ID: 22332183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of an anti-SRP myopathy with enlargement of the thymus].
    Ohta R; Mukaino A; Kinoshita I; Tsujihata M; Suzuki S
    Rinsho Shinkeigaku; 2014; 54(10):798-802. PubMed ID: 25342013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of anti-titin antibody positive nivolumab-related necrotizing myopathy with myasthenia gravis].
    Isami A; Uchiyama A; Shimaoka Y; Suzuki S; Kawachi I; Fujita N
    Rinsho Shinkeigaku; 2019 Jul; 59(7):431-435. PubMed ID: 31243249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.
    Ghosh PS; Thaera GM; Tracy JA
    Neurology; 2013 Dec; 81(24):e184. PubMed ID: 24323446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
    Hama Y; Mori-Yoshimura M; Komaki H; Suzuki S; Kohsaka H; Nishino I; Takahashi Y
    Rinsho Shinkeigaku; 2017 Oct; 57(10):567-572. PubMed ID: 28966227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of isolated amyloid myopathy.
    Liewluck T; Milone M
    Eur J Neurol; 2017 Dec; 24(12):1437-1445. PubMed ID: 28888072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid myopathy: characteristic features of a still underdiagnosed disease.
    Chapin JE; Kornfeld M; Harris A
    Muscle Nerve; 2005 Feb; 31(2):266-72. PubMed ID: 15478123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myopathy associated with amyloid angiopathy.
    Bruni J; Bilbao JM; Pritzker PH
    Can J Neurol Sci; 1977 Feb; 4(1):77-80. PubMed ID: 837267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-signal recognition particle autoantibody positive myopathy].
    Bodoki L; Vincze M; Hortobágyi T; Griger Z; Csonka T; Dankó K
    Ideggyogy Sz; 2014 Sep; 67(9-10):347-53. PubMed ID: 25518264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
    Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
    Wang L; Liu L; Hao H; Gao F; Liu X; Wang Z; Zhang W; Lv H; Yuan Y
    Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axial myopathy due to primary amyloidosis.
    Friedman Y; Paul JT; Turley J; Hazrati LN; Munoz D
    Muscle Nerve; 2007 Oct; 36(4):542-6. PubMed ID: 17405139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus in combination with methotrexate and corticosteroid for the treatment of child-onset anti-signal recognition particle antibody-positive necrotizing myopathy.
    Kobayashi I; Tozawa Y; Ueki M; Takezaki S; Watanabe S; Iwafuchi H; Yamada M; Kuwana M; Ariga T
    Scand J Rheumatol; 2017 Sep; 46(5):409-410. PubMed ID: 27897449
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
    Ashton C; Junckerstorff R; Bundell C; Hollingsworth P; Needham M
    Neuromuscul Disord; 2016 Nov; 26(11):734-740. PubMed ID: 27665513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pseudo-hypertrophic pelvi-crural amyloid myopathy in lambda light-chain myeloma. Clinical, morphological and immunocytochemical study].
    Pellissier JF; Aquilina C; Murisasco A; Toga M
    Rev Neurol (Paris); 1987; 143(2):128-36. PubMed ID: 3110902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle.
    Zheng Y; Liu L; Wang L; Xiao J; Wang Z; Lv H; Zhang W; Yuan Y
    Rheumatology (Oxford); 2015 Jun; 54(6):1017-24. PubMed ID: 25417246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.
    Apiwattanakul M; Milone M; Pittock SJ; Kryzer TJ; Fryer JP; O'toole O; Mckeon A; Lennon VA
    Muscle Nerve; 2016 Jun; 53(6):925-32. PubMed ID: 26561982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
    Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.